Skip to content

HELICOS BIOSCIENCES CORP

Delisted

CIK 1274563fmd_1XHKEZ86RVZ67D9PM6GFP75D4EManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2004 to Jun 30, 2012, 15 periods

Income Statement · Annual · Millions · USD
Line itemFY2004FY2005FY2006FY2007FY2008FY2009FY2010FY2011
Total revenues–––––343
Cost of revenue–––––110
Gross profit–––––243
Research and development–––––18145
Selling, general and administrative–––––12114
Operating income–––––(29)(23)(6)
Interest expense–––––111
Interest and investment income–––––00–
Net income–––––(28)(19)(6)
Net income to common shareholders(7)(11)(21)(37)(46)(28)(19)(6)
HELICOS BIOSCIENCES CORP financial statements · FinancialMD